World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
23334
World Ranking
18010
National Ranking
8978

Overview

Surena F. Matin is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medical fields, with emphasis on surgery, pulmonary and respiratory medicine, molecular biology, oncology, and radiology including nuclear medicine and imaging.

Their work covers several main topics, including:

  • Bladder and Urothelial Cancer Treatments
  • Renal cell carcinoma treatment
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Renal and related cancers
  • MRI in cancer diagnosis
  • Esophageal Cancer Research and Treatment

Some of their recent papers include:

  • Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma, 2020, published in Nature Medicine
  • Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline, 2023, published in The Journal of Urology
  • Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trial, 2020, published in The Lancet Oncology
  • Molecular Characterization of Upper Tract Urothelial Carcinoma in the Era of Next-generation Sequencing: A Systematic Review of the Current Literature, 2020, published in European Urology
  • The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis, 2021, published in The Journal of Urology

Frequent co-authors include:

  • José A. Karam
  • Philippe E. Spiess
  • Jay D. Raman
  • Wade J. Sexton
  • Viraj A. Master

Matin's research has been published predominantly in these venues:

  • The Journal of Urology
  • Urologic Oncology Seminars and Original Investigations
  • Journal of Clinical Oncology
  • British Journal of Urology
  • Urology

Best Publications

  • Guideline for management of the clinical T1 renal mass.

    Steven C Campbell;Andrew C Novick;Arie S. Belldegrun;Michael L Blute

  • Outcomes of radical nephroureterectomy: A series from the Upper Tract Urothelial Carcinoma Collaboration

    Vitaly Margulis;Shahrokh F. Shariat;Surena F. Matin;Ashish M. Kamat

  • Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients.

    Inderbir S. Gill;Surena F. Matin;Mihir M. Desai;Jihad H. Kaouk

  • Adjuvant Sunitinib or Sorafenib for High-Risk, Non-Metastatic Renal-Cell Carcinoma (ECOG-ACRIN E2805): A Double-Blind, Placebo-Controlled, Randomised, Phase 3 Trial

    Naomi B. Haas;Judith Manola;Robert G. Uzzo;Keith T. Flaherty

  • Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature.

    Giovanni Lughezzani;Maximilian Burger;Vitaly Margulis;Surena F. Matin

  • Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma

    Lijun Zhou;Xian-De Liu;Mianen Sun;Xuesong Zhang

  • Prospective randomized comparison of transperitoneal versus retroperitoneal laparoscopic radical nephrectomy

    Mauricio Rubinstein;Inderbir S. Gill;Monish Aron;Mete Kilciler

  • Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non–Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial

    Nizar M. Tannir;Eric Jonasch;Laurence Albiges;Emre Altinmakas

  • Urothelial Carcinoma of the Bladder and the Upper Tract: Disparate Twins

    David A. Green;Michael Rink;Evanguelos Xylinas;Surena F. Matin

  • Renal outcome 25 years after donor nephrectomy.

    David A. Goldfarb;Surena F. Matin;William E. Braun;Martin J. Schreiber

  • A Prognostic Gene Expression Signature in the Molecular Classification of Chemotherapy-naive Urothelial Cancer is Predictive of Clinical Outcomes from Neoadjuvant Chemotherapy: A Phase 2 Trial of Dose-dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin with Bevacizumab in Urothelial Cancer

    David J McConkey;Woonyoung Choi;Yu Shen;I. Ling Lee

  • Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma

    Evanguelos Xylinas;Evanguelos Xylinas;Michael Rink;Michael Rink;Eugene K. Cha;Thomas Clozel

  • Training, credentialing, proctoring and medicolegal risks of robotic urological surgery: recommendations of the society of urologic robotic surgeons.

    Kevin C. Zorn;Gagan Gautam;Arieh L. Shalhav;Ralph V. Clayman

  • Can we better select patients with metastatic renal cell carcinoma for cytoreductive nephrectomy

    Stephen H. Culp;Nizar M. Tannir;E. Jason Abel;Vitaly Margulis

  • Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.

    Surena F. Matin;Vitaly Margulis;Ashish Kamat;Christopher G. Wood

  • Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma.

    Jianjun Gao;Neema Navai;Omar Alhalabi;Arlene Siefker-Radtke

  • Residual and Recurrent Disease Following Renal Energy Ablative Therapy: A Multi-Institutional Study

    Surena F. Matin;Kamran Ahrar;Jeffrey A. Cadeddu;Debra A. Gervais

  • Phase II Presurgical Feasibility Study of Bevacizumab in Untreated Patients With Metastatic Renal Cell Carcinoma

    Eric Jonasch;Christopher G. Wood;Surena F. Matin;Shi Ming Tu

  • RECURRENCE AND SURVIVAL FOLLOWING LAPAROSCOPIC RADICAL NEPHROURETERECTOMY WITH VARIOUS FORMS OF BLADDER CUFF CONTROL

    Surena F. Matin;Inderbir S. Gill

  • Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients1

    I.S Gill;S.F Matin;M.M Desai;J.H Kaouk

Frequent Co-Authors

Christopher G. Wood
Christopher G. Wood The University of Texas MD Anderson Cancer Center
Nizar M. Tannir
Nizar M. Tannir The University of Texas MD Anderson Cancer Center
Eric Jonasch
Eric Jonasch The University of Texas MD Anderson Cancer Center
Pheroze Tamboli
Pheroze Tamboli The University of Texas MD Anderson Cancer Center
Ashish M. Kamat
Ashish M. Kamat The University of Texas MD Anderson Cancer Center
Colin P. Dinney
Colin P. Dinney The University of Texas MD Anderson Cancer Center
Jay D. Raman
Jay D. Raman Penn State Milton S. Hershey Medical Center
Louis L. Pisters
Louis L. Pisters The University of Texas MD Anderson Cancer Center
Shahrokh F. Shariat
Shahrokh F. Shariat Medical University of Vienna
Curtis A. Pettaway
Curtis A. Pettaway The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA opens doors to a broad range of health-related careers. Many students also consider allied health fields or look for flexible degree options online. An online healthcare administration degree offers training in hospital management, policy, and leadership, and can be completed faster through accelerated programs.

Nursing remains a popular pathway, especially with programs like adn to fnp programs that help registered nurses advance to family nurse practitioner roles. These flexible bridge programs enable career growth without stepping away from current jobs.

The demand for nutrition experts is also growing. Many prospective students pursue an online nutrition degree to launch careers in dietetics, wellness counseling, and food service management. These degrees often provide both foundational knowledge and practical training.

When choosing any program, accreditation is key. Students are encouraged to explore which online healthcare degree programs are recognized for their accreditation by cahme?, ensuring their education meets high industry standards and improves job prospects.

Best Scientists Citing Surena F. Matin

Trending Scientists